Dietrich ES - Search Results

1

Questioning Conclusions and Statements on the German HTA System: A Critical Perspective.

Tomeczkowski J, Heidbrede T, Leverkus F, Schmitter S, Dintsios CM, Osowski U, Herrmann KH, Bluhmki T, Marx A, Eichinger B, Basic E, Bussilliat P, Dietrich ES. Tomeczkowski J, et al. Among authors: dietrich es. Clin Pharmacol Ther. 2024 May 9. doi: 10.1002/cpt.3296. Online ahead of print. Clin Pharmacol Ther. 2024. PMID: 38721790 No abstract available.

2

How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?

Drummond M, Ciani O, Fornaro G, Jommi C, Dietrich ES, Espin J, Mossman J, de Pouvourville G. Drummond M, et al. Among authors: dietrich es. BMC Health Serv Res. 2023 May 13;23(1):484. doi: 10.1186/s12913-023-09494-5. BMC Health Serv Res. 2023. PMID: 37179322 Free PMC article. Review.

3

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany.

Pscherer S, Dietrich ES, Dippel FW, Neilson AR. Pscherer S, et al. Among authors: dietrich es. Ger Med Sci. 2010 Aug 5;8:Doc17. doi: 10.3205/000106. Ger Med Sci. 2010. PMID: 20725588 Free PMC article.

4

Trends and stabilization up to 2022 in overweight and obesity in Switzerland, comparison to France, UK, US and Australia.

Schneider H, Dietrich ES, Venetz WP. Schneider H, et al. Among authors: dietrich es. Int J Environ Res Public Health. 2010 Feb;7(2):460-72. doi: 10.3390/ijerph7020460. Epub 2010 Feb 11. Int J Environ Res Public Health. 2010. PMID: 20616985 Free PMC article.

5

[Pharmacoeconomic studies - usability for reimbursement decisions].

Dietrich ES, Nakashima T, Ahrens S. Dietrich ES, et al. Dtsch Med Wochenschr. 2010 Feb;135(8):333-8. doi: 10.1055/s-0029-1244855. Epub 2010 Feb 17. Dtsch Med Wochenschr. 2010. PMID: 20165996 Review. German.

6

Comparison of one-year costs of type 2 diabetes treatment with insulin glargine or insulin detemir in a basal supported oral therapy (BOT) in Germany.

Pscherer S, Dietrich ES, Dippel FW, Neilson AR. Pscherer S, et al. Among authors: dietrich es. Int J Clin Pharmacol Ther. 2010 Feb;48(2):129-37. doi: 10.5414/cpp48129. Int J Clin Pharmacol Ther. 2010. PMID: 20137765

7

Effects of the Statutory Health Insurance Modernization Act on the supply and expenditure situation in cases of assisted reproductive technologies in Germany.

Dietrich ES, Wevers W. Dietrich ES, et al. Fertil Steril. 2010 Feb;93(3):1011-3. doi: 10.1016/j.fertnstert.2009.07.1665. Epub 2010 Jan 12. Fertil Steril. 2010. PMID: 20060968 Free article.

8

Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England.

Dietrich ES. Dietrich ES. Int J Technol Assess Health Care. 2009 Jul;25(3):262-71. doi: 10.1017/S0266462309990110. Int J Technol Assess Health Care. 2009. PMID: 19619344

9

[Cost-benefit aspects of taxane therapy].

Dietrich ES. Dietrich ES. Pharm Unserer Zeit. 2005;34(2):138-47. doi: 10.1002/pauz.200400114. Pharm Unserer Zeit. 2005. PMID: 15803798 Review. German. No abstract available.

10

[Cost-of-illness Study for the Treatment of COPD in Germany].

Nowak D, Dietrich ES, Oberender P, Uberla K, Reitberger U, Schlegel C, Albers F, Ruckdäschel S, Welsch R. Nowak D, et al. Among authors: dietrich es. Pneumologie. 2004 Dec;58(12):837-44. doi: 10.1055/s-2004-830143. Pneumologie. 2004. PMID: 15597250 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page